4.7 Article

Differential Effects of Small Molecule Inhibitors on the Intracellular Chlamydia Infection

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Public, Environmental & Occupational Health

Sexually Transmitted Infections Treatment Guidelines, 2021

Kimberly A. Workowski et al.

MMWR Recommendations and Reports (2021)

Article Microbiology

Genome Copy Number Regulates Inclusion Expansion, Septation, and Infectious Developmental Form Conversion in Chlamydia trachomatis

Julie A. Brothwell et al.

Summary: The study shows the essential role of DNA replication in Chlamydia trachomatis for cellular development, division, and vacuole formation. Deficiencies in DNA polymerase processivity can lead to replication defects and hinder proper intracellular growth. The temperature-sensitive mutant exhibits significant differences in replication and cellular processes at different temperatures, highlighting the importance of genome replication in the pathogen's life cycle.

JOURNAL OF BACTERIOLOGY (2021)

Article Microbiology

A 2-Pyridone Amide Inhibitor of Transcriptional Activity in Chlamydia trachomatis

Carlos Nunez-Otero et al.

Summary: Chlamydia trachomatis is a strict intracellular bacterium causing sexually transmitted infections and eye infections. 2-Pyridone amides, like KSK213, are potent inhibitors of Chlamydia infectivity, specifically targeting C. trachomatis. The resistance mechanism to KSK213 involves amino acid substitutions in RNA helicase and RNase III, indicating inhibition of transcriptional machinery as the mode of action.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

Article Immunology

The Small Molecule H89 Inhibits Chlamydia Inclusion Growth and Production of Infectious Progeny

Karissa J. Munoz et al.

Summary: Chlamydia is a common intracellular bacterium causing human infections. The small molecule H89 was found to slow chlamydial inclusion growth, reduce RB replication, and significantly decrease EB production due to an effect on RB-to-EB conversion. H89, a novel anti-chlamydial compound, has unique effects on Chlamydia infection that are not related to protein kinases or vesicular transport.

INFECTION AND IMMUNITY (2021)

Review Biotechnology & Applied Microbiology

AMP-activated protein kinase: the current landscape for drug development

Gregory R. Steinberg et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Article Multidisciplinary Sciences

Replication-dependent size reduction precedes differentiation in Chlamydia trachomatis

Jennifer K. Lee et al.

NATURE COMMUNICATIONS (2018)

Article Microbiology

Expansion of the Chlamydia trachomatis inclusion does not require bacterial replication

Patrik Engstrom et al.

INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2015)

Review Cell Biology

Lipid acquisition by intracellular Chlamydiae

Cherilyn A. Elwell et al.

CELLULAR MICROBIOLOGY (2012)

Article Multidisciplinary Sciences

Mechanisms of host cell exit by the intracellular bacterium Chlamydia

Kevin Hybiske et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Multidisciplinary Sciences

A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis

Sandra Muschiol et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Multidisciplinary Sciences

Golgi-dependent transport of cholesterol to the Chlamydia trachomatis inclusion

RA Carabeo et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)